Literature DB >> 1677591

Peroxisomes of normal morphology but deficient in 3-oxoacyl-CoA thiolase in rhizomelic chondrodysplasia punctata fibroblasts.

J C Heikoop1, M Van den Berg, A Strijland, P J Weijers, R B Schutgens, W W Just, R J Wanders, J M Tager.   

Abstract

Rhizomelic Chondrodysplasia Punctata (RCDP) is an autosomal recessive disorder in which plasmalogen biosynthesis and phytanate catabolism are impaired. Peroxisomal structure and the intracellular localization of catalase, the 69 kDa peroxisomal integral membrane protein (PMP), and 3-oxoacyl-CoA thiolase were studied in cultured skin fibroblasts from control subjects and patients with RCDP. A punctate fluorescence pattern characteristic for peroxisomes was seen in control cells incubated with either anti-(catalase), anti-(69 kDa PMP) or anti-(3-oxoacyl-CoA thiolase). Incubation of mutant cells with anti-(catalase) or anti-(69 kDa PMP) resulted in the same pattern. However, when RCDP fibroblasts were incubated with a monoclonal anti-(3-oxoacyl-CoA thiolase) antibody no punctate fluorescence could be observed. Cryosections from control and RCDP cells were examined by electron microscopy using double immunogold labelling. RCDP fibroblasts contained structures indistinguishable from control peroxisomes, the membranes reacting with anti-(69 kDa PMP) and the matrix with anti-(catalase). However, the matrix of RCDP peroxisomes, unlike control peroxisomes, did not react with anti-(3-oxoacyl-CoA thiolase). We conclude that RCDP fibroblasts contain regularly shaped peroxisomes, comparable to control peroxisomes in number as well as in content of catalase and 69 kDa PMP. However, in RCDP peroxisomes the amount of 3-oxoacyl-CoA thiolase protein proved to be below the limit of detection.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1677591     DOI: 10.1016/0925-4439(91)90025-5

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  6 in total

1.  Genetic and biochemical heterogeneity in patients with the rhizomelic form of chondrodysplasia punctata--a complementation study.

Authors:  J C Heikoop; R J Wanders; A Strijland; R Purvis; R B Schutgens; J M Tager
Journal:  Hum Genet       Date:  1992-06       Impact factor: 4.132

2.  Isolated dihydroxyacetonephosphate-acyl-transferase deficiency in rhizomelic chondrodysplasia punctata: clinical presentation, metabolic and histological findings.

Authors:  H Hebestreit; R J Wanders; R B Schutgens; M Espeel; I Kerckaert; F Roels; B Schmausser; L Schrod; A Marx
Journal:  Eur J Pediatr       Date:  1996-12       Impact factor: 3.183

3.  Identification of PEX7 as the second gene involved in Refsum disease.

Authors:  Daan M van den Brink; Pedro Brites; Janet Haasjes; Anthony S Wierzbicki; John Mitchell; Michelle Lambert-Hamill; Jacqueline de Belleroche; Gerbert A Jansen; Hans R Waterham; Ronald J A Wanders
Journal:  Am J Hum Genet       Date:  2003-01-09       Impact factor: 11.025

4.  Peroxisomal bifunctional protein deficiency revisited: resolution of its true enzymatic and molecular basis.

Authors:  E G van Grunsven; E van Berkel; P A Mooijer; P A Watkins; H W Moser; Y Suzuki; L L Jiang; T Hashimoto; G Hoefler; J Adamski; R J Wanders
Journal:  Am J Hum Genet       Date:  1999-01       Impact factor: 11.025

5.  Differential protein import deficiencies in human peroxisome assembly disorders.

Authors:  A Motley; E Hettema; B Distel; H Tabak
Journal:  J Cell Biol       Date:  1994-05       Impact factor: 10.539

6.  Mammalian alanine/glyoxylate aminotransferase 1 is imported into peroxisomes via the PTS1 translocation pathway. Increased degeneracy and context specificity of the mammalian PTS1 motif and implications for the peroxisome-to-mitochondrion mistargeting of AGT in primary hyperoxaluria type 1.

Authors:  A Motley; M J Lumb; P B Oatey; P R Jennings; P A De Zoysa; R J Wanders; H F Tabak; C J Danpure
Journal:  J Cell Biol       Date:  1995-10       Impact factor: 10.539

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.